Recommended Testing and Treatment for Syphilis
The diagnosis of syphilis requires both nontreponemal (RPR or VDRL) and treponemal (FTA-ABS or TP-PA) tests, followed by treatment with parenteral penicillin G as the first-line therapy for all stages of syphilis. 1
Diagnostic Testing Algorithm
Initial Testing
Two-test approach required:
- Nontreponemal tests: VDRL (Venereal Disease Research Laboratory) or RPR (Rapid Plasma Reagin)
- Treponemal tests: FTA-ABS (Fluorescent Treponemal Antibody Absorbed) or TP-PA (T. pallidum Particle Agglutination)
Traditional screening sequence:
- Start with nontreponemal test (VDRL or RPR)
- If positive, confirm with treponemal test (FTA-ABS or TP-PA)
Reverse screening sequence (increasingly common):
- Start with automated treponemal test
- If positive, perform nontreponemal test to assess disease activity
- If treponemal positive but nontreponemal negative, confirm with a second treponemal test 2
Diagnostic Considerations
- Darkfield microscopy or direct fluorescent antibody tests of lesion exudate/tissue are definitive methods for diagnosing early syphilis 1
- Nontreponemal test results should be reported quantitatively (e.g., 1:32)
- A fourfold change in titer (equivalent to two dilutions) indicates significant difference in disease activity 1
- False-positive nontreponemal tests can occur with various medical conditions 1
- Sequential serologic tests should use the same testing method by the same laboratory 1
Special Situations
Neurosyphilis diagnosis:
HIV co-infection:
- May cause atypical serologic results (unusually high, low, or fluctuating titers)
- Consider additional testing (biopsy, direct microscopy) when serologic tests don't match clinical presentation 1
Treatment Protocol
Primary, Secondary, and Early Latent Syphilis (<1 year)
- First-line: Benzathine penicillin G 2.4 million units IM in a single dose 1
Late Latent Syphilis (>1 year) or Latent Syphilis of Unknown Duration
- First-line: Benzathine penicillin G 2.4 million units IM weekly for 3 weeks (total 7.2 million units) 1
Neurosyphilis
- First-line: Aqueous crystalline penicillin G 18-24 million units IV daily, administered as 3-4 million units every 4 hours for 10-14 days 1
Alternative Regimens (for non-pregnant, non-neurosyphilis patients with penicillin allergy)
- Doxycycline 100 mg orally twice daily for 14 days (primary, secondary, early latent) or 28 days (late latent) 3
- Tetracycline 500 mg orally four times daily for 14 days (primary, secondary, early latent) or 28 days (late latent) 3
Special Populations
- Pregnant women: Only penicillin effectively treats maternal infection and prevents congenital syphilis
- Penicillin allergy in pregnancy or neurosyphilis: Desensitization required before penicillin treatment 3
- HIV co-infection: Same treatment regimens as HIV-negative patients, but closer follow-up may be needed 1
Post-Treatment Monitoring
- Quantitative nontreponemal tests should be obtained at treatment initiation
- Titers should decline fourfold within:
- 6 months for primary/secondary syphilis
- 12-24 months for latent/late syphilis 3
- Clinical and serological evaluation recommended at 6,12, and 24 months after treatment 1
Common Pitfalls to Avoid
- Using only one type of test: Single test is insufficient for diagnosis 1
- Comparing results from different test types: RPR titers are often slightly higher than VDRL titers 1
- Using treponemal tests to monitor treatment response: These tests typically remain positive for life regardless of treatment success 1
- Inadequate follow-up: Treatment failure or reinfection can occur; serial monitoring is essential
- Jarisch-Herxheimer reaction: Patients should be advised about this potential acute febrile reaction occurring within 24 hours of treatment 1
Proper diagnosis and treatment of syphilis are critical to prevent progression to late-stage disease with potentially irreversible complications affecting multiple organ systems, particularly the cardiovascular and central nervous systems.